A detailed history of Fieldpoint Private Securities, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 7,597 shares of NVO stock, worth $772,918. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,597
Previous 4,801 58.24%
Holding current value
$772,918
Previous $533,000 58.91%
% of portfolio
0.25%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

BUY
$103.24 - $121.81 $288,659 - $340,580
2,796 Added 58.24%
7,597 $847,000
Q1 2022

Apr 07, 2022

SELL
$93.1 - $112.54 $292,799 - $353,938
-3,145 Reduced 39.58%
4,801 $533,000
Q4 2021

Jan 24, 2022

BUY
$95.88 - $117.08 $332,415 - $405,916
3,467 Added 77.41%
7,946 $890,000
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $43,645 - $55,122
517 Added 13.05%
4,479 $430,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $16,509 - $20,681
244 Added 6.56%
3,962 $397,000
Q1 2021

Apr 23, 2021

BUY
$67.06 - $75.82 $115,544 - $130,637
1,723 Added 86.37%
3,718 $251,000
Q4 2020

Jan 28, 2021

BUY
$63.89 - $73.8 $127,460 - $147,231
1,995 New
1,995 $139,000
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $14,270 - $16,003
-305 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$41.54 - $47.25 $12,669 - $14,411
305 New
305 $14,000
Q2 2018

Aug 06, 2018

SELL
$44.29 - $50.42 $335,762 - $382,234
-7,581 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$48.49 - $58.14 $34,330 - $41,163
708 Added 10.3%
7,581 $373,000
Q4 2017

Feb 15, 2018

SELL
$47.53 - $53.73 $40,020 - $45,240
-842 Reduced 10.91%
6,873 $369,000
Q3 2017

Nov 15, 2017

BUY
$41.15 - $49.22 $235,172 - $281,292
5,715 Added 285.75%
7,715 $371,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,000
2,000 $86,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.